Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Malignant germ cell tumor of ovary is a rare ovarian cancer arising from germ cells in the ovary, frequently unilateral at diagnosis which characteristically presents during adolescence with pelvic mass, fever, vaginal bleeding and acute abdomen.
Biomarker and diagnostic research for malignant germ cell tumor of ovary has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and other interventions. Pipeline includes 1 PHASE3. Research is primarily sponsored by academic and government institutions.
32 publications have been identified in PubMed for malignant germ cell tumor of ovary. Research spans Epidemiology / Natural History (28%), Case Report / Case Series (19%), and Review / Meta-Analysis (16%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 9 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 5:39 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies | 6 | 19% |
Research summaries | 5 | 16% |
Laboratory research | 5 | 16% |
Clinical study results | 4 | 13% |
Testing and diagnosis research | 2 | 6% |
New treatment approaches | 1 | 3% |
Zanfagnin V (2026). [PMID: 41887253](https://pubmed.ncbi.nlm.nih.gov/41887253/). *Arch Pathol Lab Med*. [Basic Science / Preclinical]
Ludmir D (2026). [PMID: 41448116](https://pubmed.ncbi.nlm.nih.gov/41448116/). *Gynecol Oncol*. [Epidemiology / Natural History]
Dey S (2026). [PMID: 42210622](https://pubmed.ncbi.nlm.nih.gov/42210622/). *Cancer Med*. [Epidemiology / Natural History]
Jang M (2026). [PMID: 41435655](https://pubmed.ncbi.nlm.nih.gov/41435655/). *Int J Gynecol Cancer*. [Clinical Trial Publication]
Rogalidou M (2026). [PMID: 41562819](https://pubmed.ncbi.nlm.nih.gov/41562819/). *Reports (MDPI)*. [Case Report / Case Series]
Klar M (2026). [PMID: 41797204](https://pubmed.ncbi.nlm.nih.gov/41797204/). *J Surg Oncol*. [Epidemiology / Natural History]
Ludmir D (2026). [PMID: 42090882](https://pubmed.ncbi.nlm.nih.gov/42090882/). *Gynecol Oncol*. [Epidemiology / Natural History]
Nakashima M (2026). [PMID: 41292152](https://pubmed.ncbi.nlm.nih.gov/41292152/). *Cancer Sci*. [Epidemiology / Natural History]
Laga T (2025). [PMID: 40269311](https://pubmed.ncbi.nlm.nih.gov/40269311/). *Br J Cancer*. [Basic Science / Preclinical]
De Maria F (2025). [PMID: 40275685](https://pubmed.ncbi.nlm.nih.gov/40275685/). *J Gynecol Oncol*. [Review / Meta-Analysis]
AI-curated news mentioning malignant germ cell tumor of ovary
Updated May 5, 2026
A recent study investigates the impact of lymphadenectomy on survival outcomes in patients with stage I malignant ovarian germ cell tumors. The findings contribute to understanding treatment options for this rare cancer type.
A recent study evaluates the outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors following chemotherapy and surgery. The findings contribute to understanding treatment efficacy and patient prognosis in this rare cancer population.
A recent analysis of the CORSETT database highlights fertility-sparing surgery and treatment strategies for women with malignant ovarian germ cell tumors. This study provides insights into survival outcomes, contributing to the understanding of management options for this rare cancer.